NCAM1 and myelodysplastic syndrome: It is based on FCM analysis of 10 parameters, 8 in neutrophils (FSC, SSC, CD10, CD11b, CD11c, CD16, CD45) and 2 in monocytes (CD16, CD56), and it allows to distinguish LR-MDS peripheral blood samples from normal PB samples with a sensitivity of 100% and a specificity of 93%.